

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | plasma membrane repair (GO:0001778) | 4.21152744 |
| 2 | positive regulation of histone deacetylation (GO:0031065) | 4.05116793 |
| 3 | negative regulation of fatty acid transport (GO:2000192) | 3.90655765 |
| 4 | negative regulation of cell size (GO:0045792) | 3.79355495 |
| 5 | sarcomere organization (GO:0045214) | 3.78897210 |
| 6 | actin-myosin filament sliding (GO:0033275) | 3.71213104 |
| 7 | muscle filament sliding (GO:0030049) | 3.71213104 |
| 8 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.46736137 |
| 9 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.46736137 |
| 10 | maternal placenta development (GO:0001893) | 3.43056006 |
| 11 | negative regulation of cell killing (GO:0031342) | 3.38688582 |
| 12 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.38688582 |
| 13 | barbed-end actin filament capping (GO:0051016) | 3.37296826 |
| 14 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.29525080 |
| 15 | modulation by symbiont of host cellular process (GO:0044068) | 3.23170556 |
| 16 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.22914642 |
| 17 | negative regulation of heart growth (GO:0061117) | 3.17508679 |
| 18 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 3.17508679 |
| 19 | negative regulation of necroptotic process (GO:0060546) | 3.14467388 |
| 20 | modulation by virus of host process (GO:0019054) | 3.14424100 |
| 21 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.12423401 |
| 22 | positive regulation of lamellipodium assembly (GO:0010592) | 3.09706533 |
| 23 | apoptotic cell clearance (GO:0043277) | 3.07416038 |
| 24 | regulation of skeletal muscle contraction (GO:0014819) | 3.07338707 |
| 25 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.04656938 |
| 26 | response to peptidoglycan (GO:0032494) | 3.00614579 |
| 27 | positive regulation of protein deacetylation (GO:0090312) | 2.99833308 |
| 28 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.99602498 |
| 29 | stress fiber assembly (GO:0043149) | 2.95428462 |
| 30 | ribosomal small subunit biogenesis (GO:0042274) | 2.93809534 |
| 31 | positive regulation of myotube differentiation (GO:0010831) | 2.89377720 |
| 32 | mannose metabolic process (GO:0006013) | 2.89328701 |
| 33 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.88351203 |
| 34 | cardiac myofibril assembly (GO:0055003) | 2.88071363 |
| 35 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.87825926 |
| 36 | T cell apoptotic process (GO:0070231) | 2.87578798 |
| 37 | regulation of cholesterol storage (GO:0010885) | 2.82284442 |
| 38 | actin-mediated cell contraction (GO:0070252) | 2.81149206 |
| 39 | cellular response to zinc ion (GO:0071294) | 2.79630910 |
| 40 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.78726648 |
| 41 | regulation of early endosome to late endosome transport (GO:2000641) | 2.77920012 |
| 42 | apoptotic process involved in morphogenesis (GO:0060561) | 2.76925645 |
| 43 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.76714971 |
| 44 | myofibril assembly (GO:0030239) | 2.76144309 |
| 45 | positive regulation by symbiont of host defense response (GO:0052509) | 2.75245313 |
| 46 | modulation by symbiont of host defense response (GO:0052031) | 2.75245313 |
| 47 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.75245313 |
| 48 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.75245313 |
| 49 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.75245313 |
| 50 | modulation by symbiont of host immune response (GO:0052553) | 2.75245313 |
| 51 | regulation of necrotic cell death (GO:0010939) | 2.74176236 |
| 52 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.73722096 |
| 53 | protein localization to endosome (GO:0036010) | 2.73683613 |
| 54 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.73538740 |
| 55 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.73365635 |
| 56 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.71494019 |
| 57 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.70714559 |
| 58 | positive regulation of lamellipodium organization (GO:1902745) | 2.70147733 |
| 59 | regulation of necroptotic process (GO:0060544) | 2.68986781 |
| 60 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling | 2.68962851 |
| 61 | cell-substrate junction assembly (GO:0007044) | 2.66170317 |
| 62 | modulation by virus of host morphology or physiology (GO:0019048) | 2.65762481 |
| 63 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.64014622 |
| 64 | 4-hydroxyproline metabolic process (GO:0019471) | 2.62210650 |
| 65 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.61091911 |
| 66 | focal adhesion assembly (GO:0048041) | 2.60635876 |
| 67 | cell-substrate adherens junction assembly (GO:0007045) | 2.60635876 |
| 68 | adherens junction assembly (GO:0034333) | 2.60284941 |
| 69 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.59195876 |
| 70 | detection of bacterium (GO:0016045) | 2.59149293 |
| 71 | response to laminar fluid shear stress (GO:0034616) | 2.58236082 |
| 72 | negative regulation of necrotic cell death (GO:0060547) | 2.57532542 |
| 73 | morphogenesis of an endothelium (GO:0003159) | 2.57500918 |
| 74 | endothelial tube morphogenesis (GO:0061154) | 2.57500918 |
| 75 | actin filament-based movement (GO:0030048) | 2.57201703 |
| 76 | regulation of leukocyte degranulation (GO:0043300) | 2.56116556 |
| 77 | regulation of extracellular matrix disassembly (GO:0010715) | 2.55296188 |
| 78 | positive regulation of nuclease activity (GO:0032075) | 2.55171288 |
| 79 | carnitine shuttle (GO:0006853) | 2.53974995 |
| 80 | protein retention in ER lumen (GO:0006621) | 2.53902390 |
| 81 | NADH metabolic process (GO:0006734) | 2.53367405 |
| 82 | regulation of p38MAPK cascade (GO:1900744) | 2.53137954 |
| 83 | detection of other organism (GO:0098543) | 2.53110181 |
| 84 | low-density lipoprotein particle clearance (GO:0034383) | 2.52434886 |
| 85 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.52183726 |
| 86 | regulation of integrin activation (GO:0033623) | 2.51876069 |
| 87 | cytidine metabolic process (GO:0046087) | 2.51392688 |
| 88 | cytidine catabolic process (GO:0006216) | 2.51392688 |
| 89 | cytidine deamination (GO:0009972) | 2.51392688 |
| 90 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.51023894 |
| 91 | growth hormone receptor signaling pathway (GO:0060396) | 2.49383633 |
| 92 | positive regulation of lipid storage (GO:0010884) | 2.49347220 |
| 93 | macrophage activation involved in immune response (GO:0002281) | 2.49011861 |
| 94 | skin morphogenesis (GO:0043589) | 2.48637017 |
| 95 | positive thymic T cell selection (GO:0045059) | 2.47888893 |
| 96 | positive regulation of protein dephosphorylation (GO:0035307) | 2.47653872 |
| 97 | regulation of gamma-delta T cell activation (GO:0046643) | 2.47489948 |
| 98 | natural killer cell differentiation (GO:0001779) | 2.46891372 |
| 99 | lymphocyte apoptotic process (GO:0070227) | 2.46224442 |
| 100 | NIK/NF-kappaB signaling (GO:0038061) | 2.45056188 |
| 101 | negative regulation of nucleotide catabolic process (GO:0030812) | 2.44552901 |
| 102 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.44477411 |
| 103 | pentose-phosphate shunt (GO:0006098) | 2.44474505 |
| 104 | RNA stabilization (GO:0043489) | 2.43972380 |
| 105 | mRNA stabilization (GO:0048255) | 2.43972380 |
| 106 | cortical actin cytoskeleton organization (GO:0030866) | 2.43762926 |
| 107 | viral transcription (GO:0019083) | 2.42974449 |
| 108 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.42862942 |
| 109 | response to muramyl dipeptide (GO:0032495) | 2.42466269 |
| 110 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.42346068 |
| 111 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.42270325 |
| 112 | response to parathyroid hormone (GO:0071107) | 2.41972576 |
| 113 | germinal center formation (GO:0002467) | 2.41292140 |
| 114 | regulation of defense response to virus by virus (GO:0050690) | 2.41014847 |
| 115 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.40740669 |
| 116 | pinocytosis (GO:0006907) | 2.40735884 |
| 117 | actomyosin structure organization (GO:0031032) | 2.40008303 |
| 118 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.39892306 |
| 119 | skeletal muscle adaptation (GO:0043501) | 2.39838102 |
| 120 | basement membrane organization (GO:0071711) | 2.39495919 |
| 121 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.39341466 |
| 122 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.39166393 |
| 123 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.38774458 |
| 124 | cell-cell junction maintenance (GO:0045217) | 2.38695311 |
| 125 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.37600706 |
| 126 | epithelial cell-cell adhesion (GO:0090136) | 2.37371378 |
| 127 | cellular response to virus (GO:0098586) | 2.37150121 |
| 128 | fatty acid transmembrane transport (GO:1902001) | 2.37074164 |
| 129 | heterochromatin organization (GO:0070828) | 2.36609921 |
| 130 | regulation of response to osmotic stress (GO:0047484) | 2.36525911 |
| 131 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.36224174 |
| 132 | signal complex assembly (GO:0007172) | 2.35790102 |
| 133 | activation of MAPKKK activity (GO:0000185) | 2.35109366 |
| 134 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.34811175 |
| 135 | regulation of fatty acid oxidation (GO:0046320) | 2.34696797 |
| 136 | endothelial cell chemotaxis (GO:0035767) | 2.33332932 |
| 137 | NLS-bearing protein import into nucleus (GO:0006607) | 2.32814533 |
| 138 | creatine metabolic process (GO:0006600) | 2.32803607 |
| 139 | tooth mineralization (GO:0034505) | 2.32563465 |
| 140 | neutrophil activation involved in immune response (GO:0002283) | 2.31532569 |
| 141 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.31520654 |
| 142 | response to host (GO:0075136) | 2.31520654 |
| 143 | response to host defenses (GO:0052200) | 2.31520654 |
| 144 | negative regulation of skeletal muscle tissue development (GO:0048642) | 2.31334456 |
| 145 | positive regulation of extracellular matrix organization (GO:1903055) | 2.31105615 |
| 146 | regulation of nuclease activity (GO:0032069) | 2.30788905 |
| 147 | negative regulation of phagocytosis (GO:0050765) | 2.29450835 |
| 148 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.29390179 |
| 149 | regulation of cholesterol homeostasis (GO:2000188) | 2.29360077 |
| 150 | skeletal muscle contraction (GO:0003009) | 2.28651975 |
| 151 | regulation of superoxide anion generation (GO:0032928) | 2.28430329 |
| 152 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.28289495 |
| 153 | cardiac muscle contraction (GO:0060048) | 2.28208930 |
| 154 | leukocyte aggregation (GO:0070486) | 2.27183425 |
| 155 | peptidyl-lysine dimethylation (GO:0018027) | 2.26909910 |
| 156 | regulation of mast cell degranulation (GO:0043304) | 2.25600914 |
| 157 | positive regulation of protein export from nucleus (GO:0046827) | 2.24604737 |
| 158 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.23837259 |
| 159 | positive regulation of receptor recycling (GO:0001921) | 2.23748205 |
| 160 | embryonic process involved in female pregnancy (GO:0060136) | 2.22552227 |
| 161 | negative regulation of interleukin-12 production (GO:0032695) | 2.22448150 |
| 162 | regulation of chromatin binding (GO:0035561) | 2.22146827 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.23372791 |
| 2 | MYC_22102868_ChIP-Seq_BL_Human | 3.07091884 |
| 3 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.86397864 |
| 4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.75649140 |
| 5 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.74046412 |
| 6 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.40976018 |
| 7 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.35059744 |
| 8 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.34302414 |
| 9 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.33536347 |
| 10 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.33290507 |
| 11 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.30618623 |
| 12 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.28610085 |
| 13 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.08779201 |
| 14 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.05649472 |
| 15 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.03001605 |
| 16 | MAF_26560356_Chip-Seq_TH1_Human | 2.01612995 |
| 17 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.95827768 |
| 18 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.95439774 |
| 19 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.94496622 |
| 20 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.92065004 |
| 21 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.90346151 |
| 22 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.89903518 |
| 23 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.81691520 |
| 24 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.76118804 |
| 25 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.75311280 |
| 26 | UTX_26944678_Chip-Seq_JUKART_Human | 1.71293593 |
| 27 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.70462808 |
| 28 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.69798292 |
| 29 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.69218724 |
| 30 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.68952094 |
| 31 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.67075171 |
| 32 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.66535984 |
| 33 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.64855435 |
| 34 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.60717758 |
| 35 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.60258243 |
| 36 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.59747164 |
| 37 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.57852688 |
| 38 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.57001801 |
| 39 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.56352317 |
| 40 | ATF3_27146783_Chip-Seq_COLON_Human | 1.54371127 |
| 41 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.50757801 |
| 42 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.50349475 |
| 43 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.46452875 |
| 44 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.44844823 |
| 45 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.44355641 |
| 46 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.43617551 |
| 47 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.43471505 |
| 48 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.43397325 |
| 49 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.42820415 |
| 50 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.39812694 |
| 51 | MAF_26560356_Chip-Seq_TH2_Human | 1.39425421 |
| 52 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.39264653 |
| 53 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.35451163 |
| 54 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.34819124 |
| 55 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.34636758 |
| 56 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.30522375 |
| 57 | SPI1_23127762_ChIP-Seq_K562_Human | 1.29714570 |
| 58 | KDM2B_26808549_Chip-Seq_K562_Human | 1.29452154 |
| 59 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.29045296 |
| 60 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.28922116 |
| 61 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.28922116 |
| 62 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.28634992 |
| 63 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.28085068 |
| 64 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.26091857 |
| 65 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.25258529 |
| 66 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.25176319 |
| 67 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.24554574 |
| 68 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.23915160 |
| 69 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.20473033 |
| 70 | P68_20966046_ChIP-Seq_HELA_Human | 1.20301804 |
| 71 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.19791520 |
| 72 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.18930954 |
| 73 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.18449877 |
| 74 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.18328102 |
| 75 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.17718994 |
| 76 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.17700072 |
| 77 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.17090164 |
| 78 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15432096 |
| 79 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.15237769 |
| 80 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.14889536 |
| 81 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.14872172 |
| 82 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.14823761 |
| 83 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.14619601 |
| 84 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.13409402 |
| 85 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.12596764 |
| 86 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.11860821 |
| 87 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.11708490 |
| 88 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.10236833 |
| 89 | MYB_26560356_Chip-Seq_TH2_Human | 1.10025023 |
| 90 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.09875885 |
| 91 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.09740652 |
| 92 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.09704912 |
| 93 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.09644948 |
| 94 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.09523692 |
| 95 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.09453720 |
| 96 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.08710105 |
| 97 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.08048553 |
| 98 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.07439937 |
| 99 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.06903425 |
| 100 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.06560751 |
| 101 | MYB_26560356_Chip-Seq_TH1_Human | 1.06056773 |
| 102 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.05830078 |
| 103 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.05302788 |
| 104 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.04230189 |
| 105 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.04225183 |
| 106 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.03499225 |
| 107 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.02976431 |
| 108 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.02686815 |
| 109 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.02363496 |
| 110 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.02353421 |
| 111 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.02249406 |
| 112 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.01788119 |
| 113 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00648410 |
| 114 | GATA1_19941826_ChIP-Seq_K562_Human | 1.00544448 |
| 115 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.00412626 |
| 116 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.00337804 |
| 117 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.99650588 |
| 118 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.99544220 |
| 119 | SA1_27219007_Chip-Seq_Bcells_Human | 0.99418017 |
| 120 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.99314955 |
| 121 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.98406273 |
| 122 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.98097207 |
| 123 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.98078951 |
| 124 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.97206830 |
| 125 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.94503060 |
| 126 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.92798229 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005451_abnormal_body_composition | 3.85941480 |
| 2 | MP0003705_abnormal_hypodermis_morpholog | 3.78983562 |
| 3 | MP0003303_peritoneal_inflammation | 2.87615590 |
| 4 | MP0003300_gastrointestinal_ulcer | 2.49538119 |
| 5 | MP0005076_abnormal_cell_differentiation | 2.39685969 |
| 6 | MP0009278_abnormal_bone_marrow | 2.27814503 |
| 7 | MP0004858_abnormal_nervous_system | 2.26531491 |
| 8 | MP0000751_myopathy | 2.23886574 |
| 9 | MP0003646_muscle_fatigue | 2.13098355 |
| 10 | MP0004510_myositis | 2.07532865 |
| 11 | MP0004185_abnormal_adipocyte_glucose | 2.05506800 |
| 12 | MP0008260_abnormal_autophagy | 2.05062909 |
| 13 | MP0004087_abnormal_muscle_fiber | 2.02722238 |
| 14 | MP0010352_gastrointestinal_tract_polyps | 2.01878638 |
| 15 | MP0008438_abnormal_cutaneous_collagen | 2.01401331 |
| 16 | MP0003566_abnormal_cell_adhesion | 1.98343094 |
| 17 | MP0000750_abnormal_muscle_regeneration | 1.94128423 |
| 18 | MP0000733_abnormal_muscle_development | 1.91397037 |
| 19 | MP0000749_muscle_degeneration | 1.90787278 |
| 20 | MP0002877_abnormal_melanocyte_morpholog | 1.89189517 |
| 21 | MP0004130_abnormal_muscle_cell | 1.88117963 |
| 22 | MP0002837_dystrophic_cardiac_calcinosis | 1.79619041 |
| 23 | MP0000678_abnormal_parathyroid_gland | 1.78049400 |
| 24 | MP0004084_abnormal_cardiac_muscle | 1.77649718 |
| 25 | MP0003436_decreased_susceptibility_to | 1.74289159 |
| 26 | MP0009840_abnormal_foam_cell | 1.69615877 |
| 27 | MP0010630_abnormal_cardiac_muscle | 1.65029991 |
| 28 | MP0000685_abnormal_immune_system | 1.63035013 |
| 29 | MP0002106_abnormal_muscle_physiology | 1.60931789 |
| 30 | MP0005409_darkened_coat_color | 1.50719317 |
| 31 | MP0005058_abnormal_lysosome_morphology | 1.49232481 |
| 32 | MP0000759_abnormal_skeletal_muscle | 1.48801463 |
| 33 | MP0005330_cardiomyopathy | 1.46885935 |
| 34 | MP0008961_abnormal_basal_metabolism | 1.46737523 |
| 35 | MP0005666_abnormal_adipose_tissue | 1.46187225 |
| 36 | MP0002269_muscular_atrophy | 1.45105592 |
| 37 | MP0003279_aneurysm | 1.39851513 |
| 38 | MP0003828_pulmonary_edema | 1.39381264 |
| 39 | MP0004036_abnormal_muscle_relaxation | 1.37021674 |
| 40 | MP0009379_abnormal_foot_pigmentation | 1.32867896 |
| 41 | MP0000747_muscle_weakness | 1.32446230 |
| 42 | MP0001849_ear_inflammation | 1.30222301 |
| 43 | MP0001835_abnormal_antigen_presentation | 1.26230167 |
| 44 | MP0002998_abnormal_bone_remodeling | 1.25879055 |
| 45 | MP0005397_hematopoietic_system_phenotyp | 1.25844035 |
| 46 | MP0001545_abnormal_hematopoietic_system | 1.25844035 |
| 47 | MP0000343_altered_response_to | 1.25241691 |
| 48 | MP0002249_abnormal_larynx_morphology | 1.24582281 |
| 49 | MP0005375_adipose_tissue_phenotype | 1.23426481 |
| 50 | MP0005369_muscle_phenotype | 1.23419051 |
| 51 | MP0005387_immune_system_phenotype | 1.22948475 |
| 52 | MP0001790_abnormal_immune_system | 1.22948475 |
| 53 | MP0005023_abnormal_wound_healing | 1.22711980 |
| 54 | MP0003763_abnormal_thymus_physiology | 1.20780095 |
| 55 | MP0003191_abnormal_cellular_cholesterol | 1.18043410 |
| 56 | MP0003329_amyloid_beta_deposits | 1.14545465 |
| 57 | MP0006054_spinal_hemorrhage | 1.14147878 |
| 58 | MP0001958_emphysema | 1.13804032 |
| 59 | MP0005275_abnormal_skin_tensile | 1.12431061 |
| 60 | MP0004233_abnormal_muscle_weight | 1.11502124 |
| 61 | MP0009333_abnormal_splenocyte_physiolog | 1.11360429 |
| 62 | MP0004145_abnormal_muscle_electrophysio | 1.11318023 |
| 63 | MP0010368_abnormal_lymphatic_system | 1.10347749 |
| 64 | MP0002796_impaired_skin_barrier | 1.09593285 |
| 65 | MP0004808_abnormal_hematopoietic_stem | 1.09218433 |
| 66 | MP0001544_abnormal_cardiovascular_syste | 1.09114474 |
| 67 | MP0005385_cardiovascular_system_phenoty | 1.09114474 |
| 68 | MP0006082_CNS_inflammation | 1.07877486 |
| 69 | MP0005623_abnormal_meninges_morphology | 1.06600848 |
| 70 | MP0004947_skin_inflammation | 1.04028452 |
| 71 | MP0001348_abnormal_lacrimal_gland | 1.03949531 |
| 72 | MP0002405_respiratory_system_inflammati | 1.03893053 |
| 73 | MP0001873_stomach_inflammation | 1.03091623 |
| 74 | MP0003075_altered_response_to | 1.02506326 |
| 75 | MP0010155_abnormal_intestine_physiology | 1.01784781 |
| 76 | MP0005166_decreased_susceptibility_to | 1.01112047 |
| 77 | MP0010030_abnormal_orbit_morphology | 1.00673510 |
| 78 | MP0003567_abnormal_fetal_cardiomyocyte | 0.97775442 |
| 79 | MP0000858_altered_metastatic_potential | 0.97622596 |
| 80 | MP0002148_abnormal_hypersensitivity_rea | 0.97571131 |
| 81 | MP0003091_abnormal_cell_migration | 0.97428208 |
| 82 | MP0000767_abnormal_smooth_muscle | 0.96702117 |
| 83 | MP0001533_abnormal_skeleton_physiology | 0.96331146 |
| 84 | MP0005000_abnormal_immune_tolerance | 0.96129229 |
| 85 | MP0000681_abnormal_thyroid_gland | 0.95539609 |
| 86 | MP0005464_abnormal_platelet_physiology | 0.95408758 |
| 87 | MP0003448_altered_tumor_morphology | 0.92627318 |
| 88 | MP0002452_abnormal_antigen_presenting | 0.92341963 |
| 89 | MP0001800_abnormal_humoral_immune | 0.92128344 |
| 90 | MP0003724_increased_susceptibility_to | 0.91778159 |
| 91 | MP0003221_abnormal_cardiomyocyte_apopto | 0.90756667 |
| 92 | MP0005620_abnormal_muscle_contractility | 0.90367010 |
| 93 | MP0006138_congestive_heart_failure | 0.88246435 |
| 94 | MP0000703_abnormal_thymus_morphology | 0.87675776 |
| 95 | MP0000003_abnormal_adipose_tissue | 0.87617542 |
| 96 | MP0002972_abnormal_cardiac_muscle | 0.87134130 |
| 97 | MP0005025_abnormal_response_to | 0.87011039 |
| 98 | MP0005390_skeleton_phenotype | 0.85965314 |
| 99 | MP0003453_abnormal_keratinocyte_physiol | 0.85750673 |
| 100 | MP0000266_abnormal_heart_morphology | 0.85518080 |
| 101 | MP0009785_altered_susceptibility_to | 0.85499514 |
| 102 | MP0000716_abnormal_immune_system | 0.85483330 |
| 103 | MP0000490_abnormal_crypts_of | 0.85480681 |
| 104 | MP0008775_abnormal_heart_ventricle | 0.84655461 |
| 105 | MP0002332_abnormal_exercise_endurance | 0.84588110 |
| 106 | MP0010307_abnormal_tumor_latency | 0.83237936 |
| 107 | MP0002166_altered_tumor_susceptibility | 0.83177817 |
| 108 | MP0002419_abnormal_innate_immunity | 0.81872615 |
| 109 | MP0009115_abnormal_fat_cell | 0.81821380 |
| 110 | MP0005501_abnormal_skin_physiology | 0.80864473 |
| 111 | MP0002398_abnormal_bone_marrow | 0.80256732 |
| 112 | MP0003172_abnormal_lysosome_physiology | 0.79428278 |
| 113 | MP0000604_amyloidosis | 0.78641260 |
| 114 | MP0001819_abnormal_immune_cell | 0.77758064 |
| 115 | MP0002429_abnormal_blood_cell | 0.77695921 |
| 116 | MP0002420_abnormal_adaptive_immunity | 0.77101767 |
| 117 | MP0002128_abnormal_blood_circulation | 0.76964421 |
| 118 | MP0002396_abnormal_hematopoietic_system | 0.76896019 |
| 119 | MP0005083_abnormal_biliary_tract | 0.76862712 |
| 120 | MP0002925_abnormal_cardiovascular_devel | 0.76765069 |
| 121 | MP0002138_abnormal_hepatobiliary_system | 0.76733182 |
| 122 | MP0002089_abnormal_postnatal_growth/wei | 0.76136012 |
| 123 | MP0001879_abnormal_lymphatic_vessel | 0.75855194 |
| 124 | MP0005257_abnormal_intraocular_pressure | 0.75653951 |
| 125 | MP0002722_abnormal_immune_system | 0.75085783 |
| 126 | MP0002971_abnormal_brown_adipose | 0.74796147 |
| 127 | MP0003984_embryonic_growth_retardation | 0.73998324 |
| 128 | MP0002723_abnormal_immune_serum | 0.73792029 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.93051606 |
| 2 | Exercise-induced muscle cramps (HP:0003710) | 3.91015842 |
| 3 | Exercise-induced myalgia (HP:0003738) | 3.75560633 |
| 4 | Type 1 muscle fiber predominance (HP:0003803) | 3.73597713 |
| 5 | Increased connective tissue (HP:0009025) | 3.64463492 |
| 6 | Asymmetric septal hypertrophy (HP:0001670) | 3.47857757 |
| 7 | Muscle fiber inclusion bodies (HP:0100299) | 3.37068487 |
| 8 | Cerebral aneurysm (HP:0004944) | 3.26684138 |
| 9 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.24780146 |
| 10 | Muscle fiber splitting (HP:0003555) | 3.20058421 |
| 11 | Protrusio acetabuli (HP:0003179) | 3.16820828 |
| 12 | Distal lower limb muscle weakness (HP:0009053) | 3.12730650 |
| 13 | Difficulty running (HP:0009046) | 3.12582521 |
| 14 | Ventricular tachycardia (HP:0004756) | 3.11456333 |
| 15 | Myoglobinuria (HP:0002913) | 3.10901434 |
| 16 | Ulnar deviation of the wrist (HP:0003049) | 3.07157677 |
| 17 | Difficulty climbing stairs (HP:0003551) | 2.97467080 |
| 18 | Sudden death (HP:0001699) | 2.95227507 |
| 19 | Hyporeflexia of lower limbs (HP:0002600) | 2.92176503 |
| 20 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.83745701 |
| 21 | Subaortic stenosis (HP:0001682) | 2.83745701 |
| 22 | Myopathic facies (HP:0002058) | 2.80008925 |
| 23 | Vertebral compression fractures (HP:0002953) | 2.68869681 |
| 24 | Nemaline bodies (HP:0003798) | 2.68305570 |
| 25 | Bulbar palsy (HP:0001283) | 2.66994147 |
| 26 | Obstructive sleep apnea (HP:0002870) | 2.64481629 |
| 27 | Frequent falls (HP:0002359) | 2.62950341 |
| 28 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.56571428 |
| 29 | Eczematoid dermatitis (HP:0000976) | 2.51379099 |
| 30 | Calf muscle hypertrophy (HP:0008981) | 2.50777708 |
| 31 | Right ventricular cardiomyopathy (HP:0011663) | 2.49172154 |
| 32 | Rhabdomyolysis (HP:0003201) | 2.46887362 |
| 33 | EMG: myopathic abnormalities (HP:0003458) | 2.45311513 |
| 34 | Achilles tendon contracture (HP:0001771) | 2.44992680 |
| 35 | Increased variability in muscle fiber diameter (HP:0003557) | 2.44229886 |
| 36 | Round ear (HP:0100830) | 2.43050620 |
| 37 | Increased density of long bones (HP:0006392) | 2.43042364 |
| 38 | Polycythemia (HP:0001901) | 2.42709774 |
| 39 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.39404285 |
| 40 | Premature rupture of membranes (HP:0001788) | 2.36912812 |
| 41 | Shallow orbits (HP:0000586) | 2.35296597 |
| 42 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.35295582 |
| 43 | Abnormality of the Achilles tendon (HP:0005109) | 2.27795712 |
| 44 | Distal arthrogryposis (HP:0005684) | 2.26377058 |
| 45 | Broad metatarsal (HP:0001783) | 2.24934070 |
| 46 | Distal upper limb amyotrophy (HP:0007149) | 2.21315651 |
| 47 | Upper limb amyotrophy (HP:0009129) | 2.21315651 |
| 48 | Muscle stiffness (HP:0003552) | 2.20633928 |
| 49 | Rectal prolapse (HP:0002035) | 2.15921583 |
| 50 | Abnormality of macrophages (HP:0004311) | 2.14702849 |
| 51 | Peritonitis (HP:0002586) | 2.14433311 |
| 52 | Abnormality of the calf musculature (HP:0001430) | 2.14329235 |
| 53 | Limb-girdle muscle atrophy (HP:0003797) | 2.13827679 |
| 54 | Interstitial pulmonary disease (HP:0006530) | 2.13183780 |
| 55 | Mitral valve prolapse (HP:0001634) | 2.10799291 |
| 56 | Increased cerebral lipofuscin (HP:0011813) | 2.07974108 |
| 57 | Recurrent bacterial skin infections (HP:0005406) | 2.05755718 |
| 58 | Aneurysm (HP:0002617) | 2.05361717 |
| 59 | Chronic obstructive pulmonary disease (HP:0006510) | 2.05208078 |
| 60 | Obstructive lung disease (HP:0006536) | 2.05208078 |
| 61 | Slender build (HP:0001533) | 2.04689425 |
| 62 | Lipoatrophy (HP:0100578) | 2.04555961 |
| 63 | Ulnar bowing (HP:0003031) | 2.04499933 |
| 64 | Spontaneous hematomas (HP:0007420) | 2.04210135 |
| 65 | Progressive muscle weakness (HP:0003323) | 2.02394746 |
| 66 | Axonal loss (HP:0003447) | 2.01305566 |
| 67 | Foot dorsiflexor weakness (HP:0009027) | 1.99112207 |
| 68 | Lymphangioma (HP:0100764) | 1.98967642 |
| 69 | Fragile skin (HP:0001030) | 1.98826270 |
| 70 | Mucopolysacchariduria (HP:0008155) | 1.96593935 |
| 71 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.96593935 |
| 72 | Ragged-red muscle fibers (HP:0003200) | 1.96503992 |
| 73 | Hyperacusis (HP:0010780) | 1.96409882 |
| 74 | Increased IgE level (HP:0003212) | 1.96356747 |
| 75 | Abnormality of the nasal mucosa (HP:0000433) | 1.95038509 |
| 76 | Cervical subluxation (HP:0003308) | 1.95034658 |
| 77 | Conjunctival hamartoma (HP:0100780) | 1.93802245 |
| 78 | Cellulitis (HP:0100658) | 1.93183517 |
| 79 | Bundle branch block (HP:0011710) | 1.92457272 |
| 80 | Scapular winging (HP:0003691) | 1.91726001 |
| 81 | Polygenic inheritance (HP:0010982) | 1.90923045 |
| 82 | Easy fatigability (HP:0003388) | 1.87453852 |
| 83 | Dysostosis multiplex (HP:0000943) | 1.86803825 |
| 84 | Ankle contracture (HP:0006466) | 1.86251134 |
| 85 | Genu recurvatum (HP:0002816) | 1.86115311 |
| 86 | Gastrointestinal stroma tumor (HP:0100723) | 1.85961481 |
| 87 | Hyperparathyroidism (HP:0000843) | 1.85333779 |
| 88 | Hypertensive crisis (HP:0100735) | 1.85152688 |
| 89 | Mitral regurgitation (HP:0001653) | 1.84563984 |
| 90 | Dilatation of the ascending aorta (HP:0005111) | 1.83661728 |
| 91 | Long palpebral fissure (HP:0000637) | 1.83467017 |
| 92 | Abnormality of the thoracic spine (HP:0100711) | 1.82942122 |
| 93 | Abnormality of the foot musculature (HP:0001436) | 1.82793646 |
| 94 | Multiple enchondromatosis (HP:0005701) | 1.82679867 |
| 95 | Purpura (HP:0000979) | 1.81675228 |
| 96 | Distal lower limb amyotrophy (HP:0008944) | 1.81529107 |
| 97 | Calcaneovalgus deformity (HP:0001848) | 1.81393481 |
| 98 | Hematochezia (HP:0002573) | 1.80956976 |
| 99 | Hand muscle atrophy (HP:0009130) | 1.79325574 |
| 100 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.78686954 |
| 101 | Spinal rigidity (HP:0003306) | 1.76696746 |
| 102 | Chest pain (HP:0100749) | 1.76317338 |
| 103 | Emphysema (HP:0002097) | 1.75899291 |
| 104 | Lower limb amyotrophy (HP:0007210) | 1.75677120 |
| 105 | Myocardial infarction (HP:0001658) | 1.74928007 |
| 106 | Myotonia (HP:0002486) | 1.73788543 |
| 107 | Mesangial abnormality (HP:0001966) | 1.72615911 |
| 108 | Hamartoma of the eye (HP:0010568) | 1.72598381 |
| 109 | Generalized amyotrophy (HP:0003700) | 1.72218391 |
| 110 | Thin bony cortex (HP:0002753) | 1.72051342 |
| 111 | Atrioventricular block (HP:0001678) | 1.71965569 |
| 112 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.71805453 |
| 113 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.71805453 |
| 114 | Abnormality of glycolipid metabolism (HP:0010969) | 1.71805453 |
| 115 | Broad face (HP:0000283) | 1.70945829 |
| 116 | Deformed tarsal bones (HP:0008119) | 1.70598240 |
| 117 | Fatigue (HP:0012378) | 1.70520556 |
| 118 | Stridor (HP:0010307) | 1.70491689 |
| 119 | Recurrent abscess formation (HP:0002722) | 1.70401546 |
| 120 | Thoracic kyphosis (HP:0002942) | 1.70366048 |
| 121 | Nasal polyposis (HP:0100582) | 1.69130552 |
| 122 | Hypercortisolism (HP:0001578) | 1.69079081 |
| 123 | Aortic aneurysm (HP:0004942) | 1.68123626 |
| 124 | Gastrointestinal inflammation (HP:0004386) | 1.66946406 |
| 125 | Papilloma (HP:0012740) | 1.66674541 |
| 126 | Verrucae (HP:0200043) | 1.66674541 |
| 127 | Neck muscle weakness (HP:0000467) | 1.66444919 |
| 128 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.66260025 |
| 129 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.66260025 |
| 130 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.66260025 |
| 131 | Disproportionate tall stature (HP:0001519) | 1.65674506 |
| 132 | Abnormal atrioventricular conduction (HP:0005150) | 1.64727024 |
| 133 | Abnormality of the calcaneus (HP:0008364) | 1.63740661 |
| 134 | Long toe (HP:0010511) | 1.63636301 |
| 135 | Hemorrhage of the eye (HP:0011885) | 1.60122328 |
| 136 | Myositis (HP:0100614) | 1.56886870 |
| 137 | Blue sclerae (HP:0000592) | 1.56170753 |
| 138 | Systemic lupus erythematosus (HP:0002725) | 1.55287228 |
| 139 | Supranuclear gaze palsy (HP:0000605) | 1.54812607 |
| 140 | Amyloidosis (HP:0011034) | 1.54720233 |
| 141 | Gingivitis (HP:0000230) | 1.54287166 |
| 142 | Back pain (HP:0003418) | 1.53364749 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 5.91111450 |
| 2 | PKN2 | 4.15721765 |
| 3 | PRPF4B | 3.63002126 |
| 4 | ERN1 | 3.58039503 |
| 5 | TTN | 3.48706069 |
| 6 | SMG1 | 3.04824537 |
| 7 | MAP3K10 | 2.92334177 |
| 8 | EEF2K | 2.49876831 |
| 9 | RIPK1 | 2.14530444 |
| 10 | IRAK3 | 2.13284861 |
| 11 | MAP4K1 | 2.11637526 |
| 12 | DMPK | 1.86082484 |
| 13 | RIPK4 | 1.83913482 |
| 14 | PTK6 | 1.82652025 |
| 15 | LRRK2 | 1.79857137 |
| 16 | MAP3K13 | 1.73714760 |
| 17 | ICK | 1.67727942 |
| 18 | MAP2K3 | 1.62160259 |
| 19 | BMX | 1.60083318 |
| 20 | TAOK1 | 1.49992792 |
| 21 | PDGFRA | 1.49657354 |
| 22 | ARAF | 1.48802999 |
| 23 | SIK1 | 1.45752571 |
| 24 | CDK12 | 1.42609052 |
| 25 | EPHB1 | 1.40913470 |
| 26 | TBK1 | 1.32126609 |
| 27 | TGFBR2 | 1.31774783 |
| 28 | MAP3K11 | 1.24410895 |
| 29 | IRAK4 | 1.23840172 |
| 30 | MAPK12 | 1.19995268 |
| 31 | ILK | 1.19474249 |
| 32 | PHKG1 | 1.18848080 |
| 33 | PHKG2 | 1.18848080 |
| 34 | MARK2 | 1.17735839 |
| 35 | OBSCN | 1.16038696 |
| 36 | MOS | 1.15336031 |
| 37 | ALK | 1.15050624 |
| 38 | CDC42BPA | 1.12145785 |
| 39 | NME2 | 1.09340622 |
| 40 | RPS6KA4 | 1.09277851 |
| 41 | MAP3K7 | 1.06595195 |
| 42 | ZAP70 | 1.03982457 |
| 43 | PDPK1 | 1.01097693 |
| 44 | BRAF | 0.99656405 |
| 45 | TYK2 | 0.98667810 |
| 46 | PAK4 | 0.98574997 |
| 47 | STK10 | 0.97905713 |
| 48 | DDR2 | 0.94955396 |
| 49 | FGFR4 | 0.94319055 |
| 50 | PRKD3 | 0.93400858 |
| 51 | PIM2 | 0.93358868 |
| 52 | GRK6 | 0.92000553 |
| 53 | NEK1 | 0.91733229 |
| 54 | JAK3 | 0.88189127 |
| 55 | CDK6 | 0.87807589 |
| 56 | BLK | 0.86402750 |
| 57 | CSK | 0.86205394 |
| 58 | MTOR | 0.83505684 |
| 59 | MAP3K3 | 0.81138781 |
| 60 | IRAK2 | 0.80331372 |
| 61 | LATS2 | 0.79409704 |
| 62 | PRKD2 | 0.74838572 |
| 63 | CDK4 | 0.74088021 |
| 64 | MAP3K14 | 0.73736978 |
| 65 | SIK3 | 0.71134863 |
| 66 | TYRO3 | 0.69739930 |
| 67 | PAK2 | 0.68351595 |
| 68 | CAMK1D | 0.67655514 |
| 69 | STK3 | 0.67508668 |
| 70 | MAP2K2 | 0.67252824 |
| 71 | PRKCH | 0.67109635 |
| 72 | DYRK1B | 0.66620672 |
| 73 | PDK1 | 0.66087383 |
| 74 | PTK2 | 0.65981055 |
| 75 | MAPK7 | 0.64613298 |
| 76 | JAK2 | 0.64551308 |
| 77 | PRKD1 | 0.64044973 |
| 78 | BCKDK | 0.63202716 |
| 79 | MAP3K8 | 0.62600166 |
| 80 | PDGFRB | 0.61929153 |
| 81 | STK24 | 0.61895463 |
| 82 | BTK | 0.61608193 |
| 83 | HCK | 0.61413817 |
| 84 | CAMK1G | 0.61328707 |
| 85 | JAK1 | 0.60522878 |
| 86 | CDK19 | 0.60330682 |
| 87 | TNK2 | 0.60209535 |
| 88 | FES | 0.59909416 |
| 89 | MAP3K9 | 0.59565602 |
| 90 | SIK2 | 0.58704739 |
| 91 | HIPK2 | 0.57472916 |
| 92 | NEK2 | 0.57336773 |
| 93 | FLT3 | 0.57030181 |
| 94 | EPHB2 | 0.55246865 |
| 95 | PRKG2 | 0.54212367 |
| 96 | KDR | 0.54030285 |
| 97 | RPS6KA6 | 0.53623883 |
| 98 | RPS6KL1 | 0.53603605 |
| 99 | RPS6KC1 | 0.53603605 |
| 100 | RPS6KA1 | 0.53250850 |
| 101 | FGFR3 | 0.53002328 |
| 102 | KSR2 | 0.52731967 |
| 103 | VRK2 | 0.52328818 |
| 104 | SGK3 | 0.52226604 |
| 105 | LMTK2 | 0.51524163 |
| 106 | MAP3K6 | 0.51240758 |
| 107 | PIK3CG | 0.50548454 |
| 108 | LATS1 | 0.50395157 |
| 109 | PIM1 | 0.49503745 |
| 110 | ABL2 | 0.48108030 |
| 111 | TRPM7 | 0.47241104 |
| 112 | NEK9 | 0.45894352 |
| 113 | TESK1 | 0.45408828 |
| 114 | MAPK11 | 0.45170321 |
| 115 | MAP3K1 | 0.45042259 |
| 116 | MAPK4 | 0.44335224 |
| 117 | RET | 0.43622287 |
| 118 | CSF1R | 0.43370503 |
| 119 | CAMKK1 | 0.43324146 |
| 120 | MARK3 | 0.43306241 |
| 121 | TESK2 | 0.42581021 |
| 122 | SCYL2 | 0.42400888 |
| 123 | MAPKAPK2 | 0.42261013 |
| 124 | CHUK | 0.40428489 |
| 125 | DAPK3 | 0.38857723 |
| 126 | TGFBR1 | 0.37804508 |
| 127 | TAOK2 | 0.37554294 |
| 128 | RPS6KA2 | 0.37518454 |
| 129 | PAK1 | 0.36878676 |
| 130 | AKT2 | 0.35965724 |
| 131 | NTRK1 | 0.34088172 |
| 132 | CDK9 | 0.33818095 |
| 133 | CDK7 | 0.33303767 |
| 134 | FGR | 0.33009544 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 2.12001516 |
| 2 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.04675027 |
| 3 | Other glycan degradation_Homo sapiens_hsa00511 | 2.01068353 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.97830558 |
| 5 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.97700995 |
| 6 | Leishmaniasis_Homo sapiens_hsa05140 | 1.90808372 |
| 7 | Viral myocarditis_Homo sapiens_hsa05416 | 1.87486980 |
| 8 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.69061061 |
| 9 | Insulin resistance_Homo sapiens_hsa04931 | 1.63111697 |
| 10 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.60961085 |
| 11 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.58381554 |
| 12 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.57174359 |
| 13 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.54493596 |
| 14 | Sulfur relay system_Homo sapiens_hsa04122 | 1.52413257 |
| 15 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.52319966 |
| 16 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.52055152 |
| 17 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.49182307 |
| 18 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.43684134 |
| 19 | Prion diseases_Homo sapiens_hsa05020 | 1.41824841 |
| 20 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.41387918 |
| 21 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.41379493 |
| 22 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.40028969 |
| 23 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.37521171 |
| 24 | Focal adhesion_Homo sapiens_hsa04510 | 1.37483927 |
| 25 | Bladder cancer_Homo sapiens_hsa05219 | 1.36335888 |
| 26 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.32538907 |
| 27 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.32068962 |
| 28 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.31251766 |
| 29 | Adherens junction_Homo sapiens_hsa04520 | 1.30701530 |
| 30 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.27419678 |
| 31 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.25995582 |
| 32 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.25310130 |
| 33 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.22471958 |
| 34 | Amoebiasis_Homo sapiens_hsa05146 | 1.22420870 |
| 35 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.20968669 |
| 36 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.20513517 |
| 37 | Shigellosis_Homo sapiens_hsa05131 | 1.20456614 |
| 38 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.18775240 |
| 39 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.16443272 |
| 40 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.14864827 |
| 41 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.13522615 |
| 42 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.13380059 |
| 43 | Apoptosis_Homo sapiens_hsa04210 | 1.13110369 |
| 44 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.12366534 |
| 45 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 1.11519532 |
| 46 | Legionellosis_Homo sapiens_hsa05134 | 1.11366813 |
| 47 | Tuberculosis_Homo sapiens_hsa05152 | 1.06269083 |
| 48 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.04499778 |
| 49 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.03956085 |
| 50 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.03064026 |
| 51 | Carbon metabolism_Homo sapiens_hsa01200 | 1.01888869 |
| 52 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.00211153 |
| 53 | Platelet activation_Homo sapiens_hsa04611 | 0.99977043 |
| 54 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.99961352 |
| 55 | Hepatitis B_Homo sapiens_hsa05161 | 0.98145822 |
| 56 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.98042241 |
| 57 | Galactose metabolism_Homo sapiens_hsa00052 | 0.97378554 |
| 58 | Lysosome_Homo sapiens_hsa04142 | 0.97346591 |
| 59 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.95642535 |
| 60 | Pertussis_Homo sapiens_hsa05133 | 0.92787908 |
| 61 | Lysine degradation_Homo sapiens_hsa00310 | 0.92406073 |
| 62 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.91431229 |
| 63 | Glioma_Homo sapiens_hsa05214 | 0.90914695 |
| 64 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.90896078 |
| 65 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.90427532 |
| 66 | Long-term potentiation_Homo sapiens_hsa04720 | 0.90080530 |
| 67 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.89993974 |
| 68 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.89444431 |
| 69 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.88683345 |
| 70 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.88484103 |
| 71 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.86569187 |
| 72 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.86437434 |
| 73 | Endometrial cancer_Homo sapiens_hsa05213 | 0.85541114 |
| 74 | HTLV-I infection_Homo sapiens_hsa05166 | 0.83493554 |
| 75 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.82770073 |
| 76 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.82377237 |
| 77 | Measles_Homo sapiens_hsa05162 | 0.82178284 |
| 78 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.81937778 |
| 79 | Salmonella infection_Homo sapiens_hsa05132 | 0.81639875 |
| 80 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.81620979 |
| 81 | Thyroid cancer_Homo sapiens_hsa05216 | 0.80726385 |
| 82 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.79470245 |
| 83 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.79060137 |
| 84 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.76343780 |
| 85 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.75130967 |
| 86 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.74981303 |
| 87 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.74765817 |
| 88 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.74363724 |
| 89 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.74131697 |
| 90 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.73961230 |
| 91 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.73093739 |
| 92 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.72110151 |
| 93 | Influenza A_Homo sapiens_hsa05164 | 0.72045818 |
| 94 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.71668911 |
| 95 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.70862243 |
| 96 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.69547716 |
| 97 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.68640365 |
| 98 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.67849278 |
| 99 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.67500997 |
| 100 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.66485439 |
| 101 | Endocytosis_Homo sapiens_hsa04144 | 0.65953687 |
| 102 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.65939649 |
| 103 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.65864247 |
| 104 | Colorectal cancer_Homo sapiens_hsa05210 | 0.63970381 |
| 105 | Phagosome_Homo sapiens_hsa04145 | 0.63479601 |
| 106 | Ribosome_Homo sapiens_hsa03010 | 0.62986753 |
| 107 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.62528737 |
| 108 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.62387751 |
| 109 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.60683295 |
| 110 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.60000136 |
| 111 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.59649802 |
| 112 | Prostate cancer_Homo sapiens_hsa05215 | 0.58998471 |
| 113 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.58466002 |
| 114 | Allograft rejection_Homo sapiens_hsa05330 | 0.57472247 |
| 115 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.57020808 |
| 116 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.56885832 |
| 117 | Malaria_Homo sapiens_hsa05144 | 0.53960324 |
| 118 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.53936276 |
| 119 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.53925089 |
| 120 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.53719652 |
| 121 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.53463933 |
| 122 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.52087115 |
| 123 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.50770521 |
| 124 | Hepatitis C_Homo sapiens_hsa05160 | 0.50589561 |
| 125 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.49158073 |

